NJOY says the soon-to-be-published study found that among 25 smokers not interested in quitting who were given NJOY Kings:
- 89% reduced cigarette consumption by a mean of 39% after one week,
- 32% reduced consumption by 50% or more after one week, and
- 16% quit smoking.
I'm surprised the study's duration was just ONE week (as that's just too short of time for any scientific validity or reliability), but I suspect that NJOY is probably funding the study's authors to conduct follow-ups (perhaps after 6, 12, 26, 52 weeks and/or 2 years) on the same 25 participants (and write follow-up studies).
Interestingly, Scott Leischow headed the National Cancer Institute's tobacco research program during the late 1990's and up until about 2006, when he went to the Univ of Arizona. When Leischow was at NCI, he did NOT support (nor fund and useful research on) tobacco harm reduction (regarding smokeless tobacco as a lower risk alternative for cigarettes).
About six months ago, Leischow recently moved to work at the Mayo Clinic, and as such, his new study might help influence/change Mayo's outrageous opposition to e-cigarettes.
It also helps that former US Surgeon General Richard Carmona is on NJOY's board, and that he's quoted in the press release.
Regardless of its shortcomings (and its lack of accessibility until October 1), its yet another study confirming the benefits e-cigs provide to smokers who don't want to quit.
Perhaps the only way to get more researchers, health agencies and health officials to endorse (and/or to not oppose) e-cigarettes is to pay them off, as that's what the drug industry has been doing for the past 20 years.
